Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-13

Clinical Trial Update: A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial update evaluating the long-term safety of Ecopipam in children, adolescents, and adults with Tourette's disorder; the study is currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ecopipam (Ecopipam)

Snippet

Sponsor: Emalex Biosciences Inc. | Conditions: Tourette Syndrome | Phase 3 | Status: ACTIVE_NOT_RECRUITING